相关实验视频

Updated: Jul 12, 2025

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

优化Q.Clear重建用于动态F PET成像

Elisabeth Kirkeby Lysvik^1,2, Lars Tore Gyland Mikalsen^3,4, Mona-Elisabeth Rootwelt-Revheim^5,6,7

¹Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Building 20, Gaustad Sykehus, Sognsvannveien 21, 0372, Oslo, Norway. eliski@uio.no.

|October 20, 2023

概括

在Q.Clear重建中优化β (β) 因子对于准确的动态PET成像至关重要. 在小结构中,以300-500的β因子实现精度和精度之间的平衡.

科学领域:

医疗成像医学成像
核医学是一种核医学.
定量的PET是一种PET.

背景情况:

Q.Clear是一种贝叶斯惩罚概率算法,增强了PET量化准确性.
该算法使用β惩罚因子来控制代重建期间的噪声.

研究的目的:

在动态PET扫描中确定最佳β因子以准确量化.
评估β因子对临床PET数据中的药理动力学分析的影响.

主要方法:

使用一个带有不同球体大小和获取时间的PET幻影.
使用Q.Clear与18个β-因子 (100-3500) 重建数据.
在幻影数据中评估恢复系数,变化系数和RMSE;在患者数据中计算AUC和K_i.

主要成果:

增加β-因子通常会降低恢复系数和可变性.
低的β-因子导致了小范围的高估值,而高的β-因子导致了低估值.
较高的β因子在临床数据中增加了K_i值,在β300和β1000之间观察到25.5%的变化.

结论:

最佳的β因子在动态PET成像中平衡了准确性和精度.
对于量化小结构,建议使用300-500的β因子.
较大的结构可能受益于更高的β-因子,以改善量化.

关键词:

动态PET是一种动态PET.Q. 已经清除了.量化量化量化量化恢复系数恢复系数这就是β-因子.

更多相关视频

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function

Published on: August 8, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...